# Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer

> clinical trial · VERIFIED · 2026-07-21

Status: NOT_YET_RECRUITING · Sponsor: Sun Yat-sen University · Condition: CRC (Colorectal Cancer)

- Company: Sun Yat-sen University
- Sector: CRC (Colorectal Cancer)
- Primary source: https://clinicaltrials.gov/study/NCT07714447

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.